In recent years, research has showed that the absolute number or subset of CD4+CD25+Tregs increases in peripheral blood, lymph node, and tumor tissue of patients with breast cancer and closely related to the pathological type of breast cancer and progress [4–9]. The gene discussed is CD4; the disease is neoplasm.